| Product NDC: | 63004-7734 |
| Proprietary Name: | Doral |
| Non Proprietary Name: | quazepam |
| Active Ingredient(s): | 15 mg/1 & nbsp; quazepam |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63004-7734 |
| Labeler Name: | Questcor Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018708 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19851227 |
| Package NDC: | 63004-7734-1 |
| Package Description: | 100 TABLET in 1 BOTTLE (63004-7734-1) |
| NDC Code | 63004-7734-1 |
| Proprietary Name | Doral |
| Package Description | 100 TABLET in 1 BOTTLE (63004-7734-1) |
| Product NDC | 63004-7734 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | quazepam |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19851227 |
| Marketing Category Name | NDA |
| Labeler Name | Questcor Pharmaceuticals, Inc. |
| Substance Name | QUAZEPAM |
| Strength Number | 15 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |